The genomics-focused Illumina Accelerator backs five new companies
A patented approach to skincare. New company gets start from JMU research
Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced.
James Madison Innovations, JMU's intellectual property commercialization partner, licensed the patent to DermBiont, Inc. The patent was awarded in 2013 to JMU professors Reid Harris, biology, and Kevin Minbiole, chemistry (now at Villanova University).